ALLR Allarity Therapeutics, Inc.

Fundamentals / CIK 0001860657 / USD

Allarity Therapeutics, Inc. reported $350K in revenue and a net loss of $15.73M for the trailing twelve months ended September 30, 2026, with a -3938.3% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ALLR in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$3.13M$1.56M$0-$24.94MFY 2020 Net Income: -$6.62M2020FY 2021 Net Income: -$26.65M2021FY 2022 Net Income: -$16.06M2022FY 2023 Net Income: -$11.90M2023FY 2024 Revenue: $0FY 2024 Net Income: -$24.52M2024FY 2025 Revenue: $320KFY 2025 Net Income: -$11.23M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $320K $0 -- -- -- --
Gross Profit -- -- -- -$2.27M -- --
Research & Development $6.60M $6.10M $7.10M $6.93M $14.20M $4.22M
Total Operating Expenses $12.93M $27.24M $17.13M $34.46M $26.56M $8.32M
Operating Income -$12.61M -$27.24M -$17.13M -$34.46M -$26.56M -$8.32M
EBITDA -- -$27.23M -$17.09M -$34.40M -$26.45M -$8.27M
Interest Income $801K $533K $22K $30K -- --
Interest Expense $185K $653K $498K $223K $99K $93K
Income Before Tax -$11.23M -$24.90M -$11.82M -$17.58M -- --
Income Tax Expense $0 -$381K $83K -$1.52M $133K $198K
Net Income -$11.23M -$24.52M -$11.90M -$16.06M -$26.65M -$6.62M
Basic EPS -$0.78 -$15.65 -$181,120.42 -$1,092,888,182.30 -$5,559,492,512,168.32 -$2,693,501,145,513.53
Diluted EPS -- -- -$3,624,801.27 -$1,092,888,182.30 -$5,559,492,512,168.32 --
Basic Shares Outstanding 14.4M 1.6M 113 0 0 0
Diluted Shares Outstanding -- -- 6 0 0 0

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $5.0K $0 $25K $320K $0 $0 $0 --
Research & Development $4.22M $1.34M $1.30M $1.67M $1.20M $2.32M $1.40M $1.85M
Total Operating Expenses $5.51M $2.67M $2.71M $3.24M $2.52M $4.13M $3.04M $7.32M
Operating Income -$5.51M -$2.67M -$2.69M -$2.92M -$2.52M -$4.13M -$3.04M -$7.32M
EBITDA -- -- -- -- -- -$4.12M -$3.02M --
Interest Income $205K $217K $163K $155K $187K $237K $222K $219K
Interest Expense $1.01M $719K $229K $59K $57K $12K $57K $75K
Income Before Tax -- -- -- -$3.37M -$2.81M -$2.32M -$2.73M -$7.45M
Income Tax Expense -- -- -- $0 $0 $0 $0 $0
Net Income -$6.20M -$3.40M -$2.75M -$3.37M -$2.81M -$2.32M -$2.73M -$7.45M
Basic EPS -$0.39 -$0.21 -$0.17 -- -$0.19 -$0.15 -$0.25 --
Basic Shares Outstanding 15.9M 15.9M 16.0M -- 14.7M 15.5M 11.1M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $14.69M $19.53M $166K $2.03M $19.55M $298K
Cash & Short-Term Investments $14.69M $19.53M $166K $2.03M $19.55M $298K
Other Current Assets $265K $115K $209K $1.56M $625K $335K
Total Current Assets $17.93M $22.34M $1.97M $4.97M $21.40M $1.72M
Property, Plant & Equipment, Net $330K $309K $20K $21K $8.0K $21K
Intangible Assets -- $0 $9.87M $9.55M $28.14M $30.49M
Long-Term Investments -- -- -- -- $350K $845K
Total Non-Current Assets $330K $309K $9.89M $9.58M $28.23M $31.69M
Total Assets $18.26M $22.65M $11.86M $14.54M $49.63M $33.40M
Accounts Payable $4.28M $4.18M $8.42M $6.25M $698K $2.12M
Short-Term Debt $0 -- $250K -- -- --
Total Current Liabilities $8.43M $10.84M $14.17M $11.22M $20.72M $5.53M
Long-Term Debt -- -- -- $2.64M -- --
Total Non-Current Liabilities $0 $0 $446K $1.43M $10.13M $3.43M
Total Liabilities $8.43M $10.84M $14.61M $12.65M $30.85M $8.96M
Total Debt (incl. Leases) $0 -- $250K $2.65M $107K $478K
Common Stock $3.0K $1.0K $0 $2.0K $1.0K $426K
Retained Earnings -$130.2M -$119.0M -$94.45M -$82.55M -$66.49M -$39.84M
Accumulated Other Comp. Income -$1.02M -$354K -$411K -$721K -$600K $1.38M
Total Stockholders' Equity $9.83M $11.81M -$2.75M -$113K $18.15M $24.44M
Total Equity $9.83M $11.81M -$2.75M -$113K $18.15M $26.85M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $14.09M $16.98M $19.81M $14.69M $16.89M $17.80M $25.20M $19.53M
Cash & Short-Term Investments $14.09M $16.98M $19.81M $14.69M $16.89M $17.80M $25.20M $19.53M
Other Current Assets $74K $61K $108K $265K $113K $116K $110K $115K
Total Current Assets $26.87M $31.73M $34.50M $17.93M $20.47M $20.88M $29.42M $22.34M
Property, Plant & Equipment, Net $354K $386K $420K $330K $330K $322K $308K $309K
Intangible Assets -- -- -- -- -- -- -- $0
Total Non-Current Assets $354K $386K $420K $330K $330K $322K $308K $309K
Total Assets $27.22M $32.12M $34.92M $18.26M $20.80M $21.20M $29.73M $22.65M
Accounts Payable $4.28M $4.11M $4.24M $4.28M $4.60M $4.61M $4.35M $4.18M
Short-Term Debt $21.58M $20.86M $20.08M $0 -- -- -- --
Total Current Liabilities $29.48M $28.58M $28.00M $8.43M $8.79M $9.04M $11.06M $10.84M
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $29.48M $28.58M $28.00M $8.43M $8.79M $9.04M $11.06M $10.84M
Total Debt (incl. Leases) $21.58M $20.86M $20.08M $0 -- -- -- --
Common Stock $3.0K $3.0K $3.0K $3.0K $3.0K $2.0K $2.0K $1.0K
Retained Earnings -$142.6M -$136.4M -$132.9M -$130.2M -$126.8M -$124.0M -$121.7M -$119.0M
Accumulated Other Comp. Income -$1.36M -$1.35M -$1.08M -$1.02M -$2.30M -$2.46M -$630K -$354K
Total Stockholders' Equity -$2.26M $3.54M $6.92M $9.83M $12.01M $12.17M $18.67M $11.81M
Total Equity -$2.26M $3.54M $6.92M $9.83M $12.01M $12.17M $18.67M $11.81M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$11.23M -$24.52M -$11.90M -$16.06M -$26.65M -$6.62M
Depreciation & Amortization -- $9.0K $37K $60K $106K $46K
Stock-Based Compensation $482K $71K -$71K $1.75M $6.37M $616K
Change in Receivables -- -- -- -- -- $95K
Change in Payables -$1.14M -$4.11M $2.17M $6.21M -$1.31M -$62K
Operating Cash Flow -$14.82M -$17.35M -$12.74M -$16.82M -$14.89M -$7.25M
Capital Expenditure -$8.0K -$298K $0 -$18K -- -$3.0K
Free Cash Flow -$14.83M -$17.65M -$12.74M -$16.84M -- -$7.25M
Investing Cash Flow -$8.0K -$298K $0 $791K $1.00M -$3.0K
Common Stock Issued $11.14M $37.35M $0 -- $32.12M $3.70M
Share Repurchases -$3.19M $0 -- -- -- --
Financing Cash Flow $10.65M $36.79M $10.99M -$1.31M $33.82M $6.03M
Net Change in Cash -$4.18M $19.14M -$1.75M -$17.34M $19.94M -$1.22M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$6.20M -$3.40M -$2.75M -$3.37M -$2.81M -$2.32M -$2.73M -$7.45M
Depreciation & Amortization -- -- -- -- -- $12K $11K --
Stock-Based Compensation $191K $188K $160K $47K $132K $164K $139K $64K
Change in Payables $171K -$122K -$47K -$1.57M -$3.0K $259K $177K -$485K
Operating Cash Flow -$2.88M -$2.56M -$4.49M -$3.24M -$3.41M -$5.48M -$2.69M -$3.21M
Capital Expenditure $0 $0 -$64K -$8.0K $0 $0 $0 --
Free Cash Flow -$2.88M -$2.56M -$4.56M -$3.25M -$3.41M -$5.48M -$2.69M --
Investing Cash Flow $0 $0 -$64K -$8.0K $0 $0 $0 --
Common Stock Issued $0 $0 $0 $0 $0 $0 $11.14M $4.24M
Share Repurchases $0 $0 -$262K -$484K -$141K -$2.56M $0 --
Financing Cash Flow $0 $0 $19.74M -$240K $2.31M -$2.56M $11.14M $4.24M
Net Change in Cash -- -- $15.18M -$3.49M -$1.10M -$8.05M $8.46M $731K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -3939.1% -- -- -- -- --
Net Profit Margin -3509.7% -- -- -- -- --
Return on Equity (ROE) -114.3% -207.6% -- -- -146.8% -27.1%
Return on Assets (ROA) -61.5% -108.2% -100.3% -110.4% -53.7% -19.8%
Current Ratio 2.13x 2.06x 0.14x 0.44x 1.03x 0.31x
Quick Ratio 1.74x 1.80x 0.01x 0.18x 0.94x 0.05x
Debt to Equity 0.00x -- -- -- 0.01x 0.02x

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -3938.3% -3129.0% -3552.8% -3939.1% -- -- -- --
Net Profit Margin -4493.7% -3575.1% -3260.6% -3509.7% -- -- -- --
Return on Equity (ROE) -- -348.8% -162.6% -114.3% -127.5% -198.0% -125.4% -207.6%
Return on Assets (ROA) -57.8% -38.4% -32.2% -61.5% -73.6% -113.6% -78.7% -108.2%
Current Ratio 0.91x 1.11x 1.23x 2.13x 2.33x 2.31x 2.66x 2.06x
Quick Ratio 0.48x 0.59x 0.71x 1.74x 1.92x 1.97x 2.28x 1.80x
Debt to Equity -- 5.90x 2.90x 0.00x -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001860657) · from March 31, 2020 Data through September 30, 2026 · synced Nov 21, 2026, 05:05 UTC · Open in terminal